J BREAST CANC 2019 10.4048/jbc.2019.22.e48
Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm
Alsharif1, E; Ryu, JM; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Lee, JE
JAMA Oncol 2019 10.1001/jamaoncol.2019.0620
Insights Into Breast Cancer in the East vs the West: A Review
Yap1, YS; Lu, YS; Tamura, K; Lee, JE; Ko, EY; Park, YH; Cao, AY; Lin, CH; Toi, M; Wu, J; Lee, SC
BREAST CANCER RES TR 2019 10.1007/s10549-019-05214-y
Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy
Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, JE; Lee, SK
Front Oncol 2019 10.3389/fonc.2019.00667
Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer
Kwon1, MJ; Lee, JE; Jeong, J; Woo, SU; Han, J; Kang, BI; Kim, JE; Moon, Y; Lee, SB; Lee, S; Choi, YL; Kwon, Y; Song, K; Gong, G; Shin, YK
BREAST CANCER RES TR 2019 10.1007/s10549-019-05244-6
Childbirth in young Korean women with previously treated breast cancer: The SMARTSHIP study
Lee1, HM; Kim, BW; Park, S; Park, S; Lee, JE; Choi, YJ; Kim, SY; Woo, SU; Youn, HJ; Lee, I
MEDICINE 2019 10.1097/MD.0000000000015871
Radiomics signature on 3T dynamic contrast-enhanced magnetic resonance imaging for estrogen receptor-positive invasive breast cancers Preliminary results for correlation with Oncotype DX recurrence scores
Nam1, KJ; Park, H; Ko, ES; Lim, Y; Cho, HH; Lee, JE
BREAST CANCER RES TR 2019 10.1007/s10549-019-05157-4
Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort
Jung1, J; Han, W; Lee, ES; Jung, SY; Han, JH; Noh, DY; Kim, Y; Choi, HJ; Lee, JE; Nam, SJ; Lee, JW; Kim, HJ; Um, E; Kim, JH; Park, S; Cho, YU
CANCER RES TREAT 2019 10.4143/crt.2018.342
Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance
Kim1, HK; Park, KH; Kim, Y; Park, SE; Lee, HS; Lim, SW; Cho, JH; Kim, JY; Lee, JE; Ahn, JS; Im, YH; Yu, JH; Park, YH
ANN SURG TREAT RES 2019 10.4174/astr.2019.96.4.169
Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer
Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, JH; Lee, JE; Lee, SK
ONCOLOGIST 2019 10.1634/theoncologist.2018-0184
Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study
Kang1, D; Kim, IR; Choi, EK; Im, YH; Park, YH; Ahn, JS; Lee, JE; Nam, SJ; Lee, HK; Park, JH; Lee, DY; Lacouture, ME; Guallar, E; Cho, J
ONCOL REP 2019 10.3892/or.2018.6910
TP53 upregulates -smooth muscle actin expression in tamoxifen-resistant breast cancer cells
Kim1, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE
PLoS One 2019 10.1371/journal.pone.0212309
Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment
Kwon1, AY; Park, HY; Hyeon, J; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY
EJSO-EUR J SURG ONC 2019 10.1016/j.ejso.2018.09.011
A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning
Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE
BREAST CANCER RES TR 2019 10.1007/s10549-018-4947-z
Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?
Lee1, SK; Kim, SW; Yu, JH; Lee, JE; Kim, JY; Woo, J; Lee, S; Kim, EK; Moon, HG; Ko, SS; Nam, SJ
BREAST CANCER RES TR 2019 10.1007/s10549-018-4981-x
A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients
Hwang1, HW; Jung, H; Hyeon, J; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Choi, M; Cho, SY; Cho, EY
NUTRIENTS 2019 10.3390/nu11010037
Serum Trace Elements and Their Associations with Breast Cancer Subgroups in Korean Breast Cancer Patients
Choi1, R; Kim, MJ; Sohn, I; Kim, S; Kim, I; Ryu, JM; Choi, HJ; Kim, JM; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Lee, SY
HERED CANCER CLIN PR 2019 10.1186/s13053-018-0103-3
The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans
Kim1, H; Choi, DH; Park, W; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Jung, BY
BREAST CANCER RES TR 2019 10.1007/s10549-018-5015-4
Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea
Ryu1, JM; Choi, HJ; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Choi, DH; Park, YH; Kim, JW; Seo, JS; Park, JH; Lee, JE; Kim, SW
BREAST CANCER RES TR 2018 10.1007/s10549-018-4948-y
Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer
Ryu1, JM; Choi, HJ; Kim, I; Lee, SK; Yu, J; Kim, JE; Kang, B; Lee, JE; Nam, SJ; Kim, SW
ANALYST 2018 10.1039/c8an01752b
Formation of size-controllable tumour spheroids using a microfluidic pillar array (mu FPA) device
Lim1, W; Hoang, HH; You, D; Han, J; Lee, JE; Kim, S; Park, S
J BREAST CANC 2018 10.4048/jbc.2018.21.e54
Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis
Choi1, HJ; Kim, I; Alsharif, E; Park, S; Kim, JM; Ryu, JM; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE
KAOHSIUNG J MED SCI 2018 10.1016/j.kjms.2018.07.003
Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy-treated triple negative breast cancer
Bae1, SY; Jung, SP; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ
J MED GENET 2018 10.1136/jmedgenet-2018-105565
Reclassification of BRCA1 and BRCA2 variants of uncertain significance: a multifactorial analysis of multicentre prospective cohort
Lee1, JS; Oh, S; Park, SK; Lee, MH; Lee, JW; Kim, SW; Son, BH; Noh, DY; Lee, JE; Park, HL; Kim, MJ; Cho, SI; Lee, YK; Park, SS; Seong, MW
J BREAST CANC 2018 10.4048/jbc.2018.21.e50
Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study
Choi1, HJ; Kum, JM; Ryu, JM; Kim, I; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW
PHYTOMEDICINE 2018 10.1016/j.phymed.2018.08.004
Berberine down-regulates IL-8 expression through inhibition of the EGFR/ MEK/ERK pathway in triple-negative breast cancer cells
Kim1, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE
PLoS One 2018 10.1371/journal.pone.0207155
BCT score predicts chemotherapy benefit in Asian patients with hormone receptor- positive, HER2-negative, lymph node-negative breast cancer
Kwon1, MJ; Lee, SB; Han, J; Lee, JE; Lee, JW; Gong, G; Beitsch, PD; Nem, SJ; Ahn, SH; Nam, BH; Shin, YK
BREAST CANCER RES TR 2018 10.1007/s10549-018-4863-2
Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy
Lee1, DY; Park, YH; Lee, JE; Choi, D
CLIN CANCER RES 2018 10.1158/1078-0432.CCR-17-3783
Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer
Park1, H; Lim, Y; Ko, ES; Cho, HH; Lee, JE; Han, BK; Ko, EY; Choi, JS; Park, KW
NAT GENET 2018 10.1038/s41588-018-0209-6
Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy
Lee1, JK; Liu, ZQ; Sa, JK; Shin, S; Wang, JG; Bordyuh, M; Cho, H; Elliott, O; Chu, T; Choi, SW; Rosenbloom, DIS; Lee, IH; Shin, YJ; Kang, HJ; Kim, D; Kim, SY; Sim, MH; Kim, J; Lee, T; Seo, YJ; Shin, H; Lee, M; Kim, SH; Kwon, YJ; Oh, JW; Song, M; Kim, M; Kong, DS; Choi, JW; Seol, HJ; Lee, JI; Kim, ST; Park, JO; Kim, KM; Song, SY; Lee, JW; Kim, HC; Lee, JE; Choi, MG; Seo, SW; Shim, YM; Zo, JI; Jeong, BC; Yoon, Y; Ryu, GH; Kim, NKD; Bae, JS; Park, WY; Lee, J; Verhaak, RGW; Iavarone, A; Lee, J; Rabadan, R; Nam, DH
CLIN BREAST CANCER 2018 10.1016/j.clbc.2018.04.008
Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy
Kim1, HJ; Lee, MH; Lee, JE; Park, S; Lee, ES; Kang, YJ; Shin, HN; Kim, SI; Lee, JH; Im, SA; Ahn, SH; Lee, KS; Sohn, J; Kim, S; Nam, SJ; Han, W
CLIN BREAST CANCER 2018 10.1016/j.clbc.2018.04.010
Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment
Cho1, WK; Choi, DH; Park, W; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY; Ahn, S
BREAST CANCER RES TR 2018 10.1007/s10549-018-4858-z
Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort
Kim1, JY; Lim, JE; Jung, HH; Cho, SY; Cho, EY; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
ONCOLOGY-BASEL 2018 10.1159/000488944
Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype
Bae1, SY; Jung, SP; Jung, ES; Park, SM; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ
RADIOLOGY 2018 10.1148/radiol.2018171987
Preoperative Axillary US in Early-Stage Breast Cancer: Potential to Prevent Unnecessary Axillary Lymph Node Dissection
Kim1, GR; Choi, JS; Han, BK; Lee, JE; Nam, SJ; Ko, EY; Ko, ES; Lee, SK
J BREAST CANC 2018 10.4048/jbc.2018.21.2.173
Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer
Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE
J BREAST CANC 2018 10.4048/jbc.2018.21.2.206
Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy?
Cho1, WK; Park, W; Choi, DH; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY
J BREAST CANC 2018 10.4048/jbc.2018.21.2.222
Verification of a Western Nomogram for Predicting Oncotype DX (TM) Recurrence Scores in Korean Patients with Breast Cancer
Kim1, JM; Ryu, JM; Kim, I; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE
EUR J CANCER PREV 2018 10.1097/CEJ.0000000000000353
Association between mammographic density and tumor marker-defined breast cancer subtypes: a case-control study
Shin1, J; Lee, JE; Ko, HY; Nguyen, TL; Nam, SJ; Hopper, JL; Song, YM
WORLD J SURG 2018 10.1007/s00268-017-4342-7
Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer
Park1, S; Lee, JE; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Yu, J; Kim, SW; Nam, SJ
NAT COMMUN 2018 10.1038/s41467-018-04129-4
Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures
Kan1, ZY; Ding, Y; Kim, J; Jung, HH; Chung, W; Lal, S; Cho, S; Fernandez-Banet, J; Lee, SK; Kim, SW; Lee, JE; Choi, YL; Deng, S; Kim, JY; Ahn, JS; Sha, Y; Mu, XJ; Nam, JY; Im, YH; Lee, S; Park, WY; Nam, SJ; Park, YH
PLoS One 2018 10.1371/journal.pone.0195756
Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer
Nam1, SY; Ko, ES; Lim, Y; Han, BK; Ko, EY; Choi, JS; Lee, JE
J BREAST CANC 2018 10.4048/jbc.2018.21.1.21
Berberine Suppresses Fibronectin Expression through Inhibition of c-Jun Phosphorylation in Breast Cancer Cells
Jeong1, Y; You, D; Kang, HG; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Kim, S
J BREAST CANC 2018 10.4048/jbc.2018.21.1.91
Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy
Park1, JH; Lee, SK; Lee, JE; Kim, SW; Nam, SJ; Kim, JY; Ahn, JS; Park, W; Yu, J; Park, YH
TRANSL ONCOL 2018 10.1016/j.tranon.2017.10.002
Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast
Kim1, JY; Yu, JH; Nam, SJ; Kim, SW; Lee, SK; Park, WY; Noh, DY; Nam, DH; Park, YH; Han, W; Lee, JE
CLIN BREAST CANCER 2018 10.1016/j.clbc.2017.06.003
Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane
Park1, S; Lee, JE; Yu, J; Paik, HJ; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Kim, SW; Nam, SJ; Kim, EK; Kang, E; Yang, EJ
CELL PHYSIOL BIOCHEM 2018 10.1159/000487171
Berberine Suppresses Cell Motility Through Downregulation of TGF-beta 1 in Triple Negative Breast Cancer Cells
Kim1, S; Lee, J; You, D; Jeong, Y; Jeon, M; Yu, J; Kim, SW; Nam, SJ; Lee, JE
QUAL LIFE RES 2018 10.1007/s11136-017-1723-1
Development and validation of the smart management strategy for health assessment tool-short form (SAT-SF) in cancer survivors
Yun1, YH; Jung, JY; Sim, JA; Lee, J; Noh, DY; Han, W; Park, KJ; Jeong, SY; Park, JW; Wu, HG; Chie, EK; Kim, HJ; Jung, KH; Zo, JI; Kim, S; Lee, JE; Nam, SJ; Lee, ES; Oh, JH; Kim, YW; Kim, YT; Shim, YM
GENOME RES 2018 10.1101/gr.223263.117
SIDR: simultaneous isolation and parallel sequencing of genomic DNA and total RNA from single cells
Han1, KY; Kim, KT; Joung, JG; Son, DS; Kim, YJ; Jo, A; Jeon, HJ; Moon, HS; Yoo, CE; Chung, W; Eum, HH; Kim, S; Kim, HK; Lee, JE; Ahn, MJ; Lee, HO; Park, D; Park, WY
BMC CANCER 2018 10.1186/s12885-017-3965-2
A train the trainer program for healthcare professionals tasked with providing psychosocial support to breast cancer survivors
Park1, E; Yoon, J; Choi, EK; Kim, IR; Kang, D; Lee, SK; Lee, JE; Nam, SJ; Ahn, JS; Visser, A; Cho, J
BREAST CANCER RES TR 2017 10.1007/s10549-017-4472-5
Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society
Ryu1, JM; Yu, J; Kim, SI; Kim, KS; Moon, HG; Choi, JE; Jeong, J; Byun, KD; Nam, SJ; Lee, JE; Lee, SK; Kim, SW
BMB REP 2017 10.5483/BMBRep.2017.50.12.096
Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells
You1, D; Jung, SP; Jeong, Y; Bae, SY; Lee, JE; Kim, S
ONCOTARGET 2017 10.18632/oncotarget.22220
Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer
Woo1, HI; Lee, SK; Kim, J; Kim, SW; Yu, J; Bae, SY; Lee, JE; Nam, SJ; Lee, SY
PSYCHO-ONCOL 2017 10.1002/pon.4408
Who are happy survivors? Physical, psychosocial, and spiritual factors associated with happiness of breast cancer survivors during the transition from cancer patient to survivor
Kang1, D; Kim, IR; Choi, EK; Yoon, JH; Lee, SK; Lee, JE; Nam, SJ; Han, W; Noh, DY; Cho, J
NAT COMMUN 2017 10.1038/s41467-017-01470-y
Prevalence and detection of low-allele-fraction variants in clinical cancer samples
Shin1, HT; Choi, YL; Yun, JW; Kim, NKD; Kim, SY; Jeon, HJ; Nam, JY; Lee, C; Ryu, D; Kim, SC; Park, K; Lee, E; Bae, JS; Son, DS; Joung, JG; Lee, J; Kim, ST; Ahn, MJ; Lee, SH; Ahn, JS; Lee, WY; Oh, BY; Park, YH; Lee, JE; Lee, KH; Kim, HC; Kim, KM; Im, YH; Park, K; Park, PJ; Park, WY
CLIN BREAST CANCER 2017 10.1016/j.clbc.2017.03.014
Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis
Ryu1, JM; Lee, SK; Kim, JY; Yu, JH; Kim, SW; Lee, JE; Han, SH; Jung, YS; Nam, SJ
BREAST CANCER RES TR 2017 10.1007/s10549-017-4423-1
Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy
Kang1, YJ; Han, W; Park, S; You, J; Yi, HW; Park, S; Nam, S; Kim, JH; Yun, KW; Kim, HJ; Ahn, SH; Park, S; Lee, JE; Lee, ES; Noh, DY; Lee, JW
ONCOTARGET 2017 10.18632/oncotarget.21198
Circulating tumor DNA shows variable clonal response of breast cancer during neoadjuvant chemotherapy
Kim1, JY; Park, D; Son, DS; Nam, SJ; Kim, SW; Jung, HH; Kim, YJ; Park, G; Park, WY; Lee, JE; Park, YH
J BREAST CANC 2017 10.4048/jbc.2017.20.3.297
Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry
You1, K; Park, S; Ryu, JM; Kim, I; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE
J BREAST CANC 2017 10.4048/jbc.2017.203.270
Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy
Kim1, I; Ryu, JM; Kim, JM; Choi, HJ; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ
ONCOTARGET 2017 10.18632/oncotarget.10843
Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction
Jeon1, M; You, D; Bae, SY; Kim, SW; Nam, SJ; Kim, HH; Kim, S; Lee, JE
ASIA-PAC J CLIN ONCO 2017 10.1111/ajco.12652
Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy
Kim1, H; Park, W; Huh, SJ; Choi, DH; Noh, JM; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Cho, EY
BREAST CANCER RES TR 2017 10.1007/s10549-017-4234-4
MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer
Han1, J; Choi, YL; Kim, H; Choi, JY; Lee, SK; Lee, JE; Choi, JS; Park, S; Choi, JS; Kim, YD; Nam, SJ; Nam, BH; Kwon, MJ; Shin, YK
PSYCHIATRY INVESTIG 2017 10.4306/pi.2017.14.4.491
Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study
Heo1, JY; Yi, H; Fava, M; Mischoulon, D; Kim, K; Yoon, S; Jeon, HJ; Lee, JE
Sci Rep. 2017 Mar 28;7:45554. doi: 10.1038/srep45554.
A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2-early breast cancer
Gong G11, Kwon MJ2,3, Han J4, Lee HJ1, Lee SK5, Lee JE5, Lee SH6, Park S7, Choi JS7, Cho SY8, Ahn SH9, Lee JW9, Cho SR4, Moon Y4, Nam BH10, Nam SJ5, Choi YL8,11,12, Shin YK7,13,14.
J Breast Cancer. 2017 Mar;20(1):91-97. doi: 10.4048/jbc.2017.20.1.91. Epub 2017 Mar 24.
Fertility Rates in Young Korean Breast Cancer Patients Treated with Gonadotropin-Releasing Hormone and Chemotherapy
Kim I11, Ryu JM1, Paik HJ1, Park S1, Bae SY1, Lee SK1, Yu J1, Kim SW1, Nam SJ1, Lee JE1.
J Breast Cancer. 2017 Mar;20(1):74-81. doi: 10.4048/jbc.2017.20.1.74. Epub 2017 Mar 24.
Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study
Ryu JM11, Paik HJ1, Park S1, Yi HW1, Nam SJ1, Kim SW1, Lee SK1, Yu J1, Bae SY1, Lee JE1.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10(2):1738-1746
Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) in pretherapeutic breast cancer core biopsies: Anti-tumoral effect of immune cells associated with neoadjuvant chemotherapy
Yoon N1, Han KM, Cho SY, Kim SW, Lee JE, Nam SJ, Cho EY
Clin Breast Cancer. 2017 Feb;17(1):e19-e29. doi: 10.1016/j.clbc.2016.06.020. Epub 2016 Jul 9.
Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer
Park S11, Lee JE2, Paik HJ1, Ryu JM1, Bae SY1, Lee SK1, Kim SW1, Nam SJ1.
Breast Cancer Res Treat. 2017 Jan;161(1):95-102. doi: 10.1007/s10549-016-4034-2. Epub 2016 Oct 25.
Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer
Kim H11, Cho DY2, Choi DH3,4, Oh M2, Shin I2, Park W5, Huh SJ5, Nam SJ6, Lee JE6, Kim SW6.
Medicine (Baltimore). 2017 Jan;96(1):e5746. doi: 10.1097/MD.0000000000005746.
Conditional disease-free survival among patients with breast cancer
Paik HJ11, Lee SK, Ryu JM, Park S, Kim I, Bae SY, Yu J, Lee JE, Kim SW, Nam SJ.
Breast. 2016 Dec;30:111-117. doi: 10.1016/j.breast.2016.08.011. Epub 2016 Sep 30.
Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype
Alramadhan M11, Ryu JM1, Rayzah M1, Nam SJ1, Kim SW1, Yu J1, Lee SK1, Bae SY1, Park S1, Paik HJ1, Lee JE2.
Chem Biol Interact. 2016 Oct 25;258:126-33. doi: 10.1016/j.cbi.2016.08.021. Epub 2016 Aug 25.
Elevated IL-1 beta expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone
Jeon M11, Han J2, Nam SJ2, Lee JE3, Kim S4.
Breast Cancer Res Treat. 2016 Oct;159(3):489-98. doi: 10.1007/s10549-016-3943-4. Epub 2016 Sep 2.
Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society
Ryu JM11, Lee HJ2, Yoon TI3, Lee ES4, Lee SJ5, Jung JH6, Chae BJ7, Nam SJ1, Lee JE1, Lee SK1, Bae SY1, Yu J1, Kim SW8; Korean Breast Cancer Society Consortium.
Cancer Res Treat. 2016 Oct;48(4):1382-1388. Epub 2016 Mar 11.
Clinicopathologic Features and Long-Term Outcomes of Elderly Breast Cancer Patients: Experiences at a Single Institution in Korea
Kim HK11, Ham JS1, Byeon S1, Yoo KH1, Jung KS1, Song HN1, Cho J1, Lee JY1, Lim SH1, Kim HS1, Kim JY1, Lee JE2, Kim SW2, Nam SJ2, Lee SK2, Bae SY2, Ahn JS1, Im YH1, Park YH1.
PLoS One. 2016 Oct 31;11(10):e0165814. doi: 10.1371/journal.pone.0165814. eCollection 2016.
Body Mass Index with Tumor F-18-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer
Hyun SH11, Ahn HK2, Lee JH1, Choi JY1, Kim BT1, Park YH3, Im YH3, Lee JE4, Nam SJ4, Lee KH1.
Oncol Rep. 2016 Sep;36(3):1717-22. doi: 10.3892/or.2016.4972. Epub 2016 Jul 25.
STC-1 expression is upregulated through an Akt/NF-B-dependent pathway in triple-negative breast cancer cells
Jeon M11, Han J1, Nam SJ1, Lee JE1, Kim S1.
J Breast Cancer. 2016 Sep;19(3):330-333. Epub 2016 Sep 23.
Radiologic Findings of Primary Mucinous Cystadenocarcinoma of the Breast: A Report of Two Cases and a Literature Review
Seong M11, Ko EY1, Han BK1, Cho SY2, Cho EY2, Lee SK3, Lee JE3.
PLoS One. 2016 Sep 20;11(9):e0163254. doi: 10.1371/journal.pone.0163254. eCollection 2016.
Clinicopathological Features and Prognostic Factors Affecting Survival Outcomes in Isolated Locoregional Recurrence of Breast Cancer: Single-Institutional Series
Lee MY11, Chang WJ1, Kim HS1, Lee JY1, Lim SH1, Lee JE2, Kim SW2, Nam SJ2, Ahn JS1, Im YH1, Park YH1.
World J Surg. 2016 Aug;40(8):2028-35. doi: 10.1007/s00268-016-3487-0.
Feasibility of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Breast Cancer Patients with Tumor-Nipple Distance Less Than 2.0 cm
Ryu JM11, Nam SJ1, Kim SW1, Lee SK1, Bae SY1, Yi HW1, Park S1, Paik HJ1, Lee JE2.
Tumour Biol. 2016 Aug;37(8):11397-407. doi: 10.1007/s13277-016-5000-7. Epub 2016 Mar 16.
Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-beta 2 expression
Kim S11, Han J2, Jeon M2,3, You D2,3, Lee J2, Kim HJ2, Bae S2, Nam SJ2, Lee JE4,5.
SCIENTIFIC REPORTS, AUG 22 2016, 6, DOI: 10.1038/srep31804
The relationship between nuclear factor (NF)-kappa B family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment
Kim JY1, Jung HH, Ahn S, Bae S, Lee SK, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH
Cancer Res Treat. 2016 Jul;48(3):955-61. doi: 10.4143/crt.2015.191. Epub 2016 Jan 19.
Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer
Kim H11, Cho DY2, Choi DH3, Jung GH2, Shin I2, Park W3, Huh SJ3, Nam SJ4, Lee JE4, Gil WH4, Kim SW4.
Genes Chromosomes Cancer. 2016 Jun;55(6):495-504. doi: 10.1002/gcc.22351. Epub 2016 Mar 3.
Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade
Yoon N11, Bae GE2, Kang SY1, Choi MS1, Hwang HW1, Kim SW3, Lee JE3, Nam SJ3, Gong G4, Lee HJ4, Bae YK5, Lee A6, Cho EY1.
J Breast Cancer. 2016 Jun;19(2):169-75. doi: 10.4048/jbc.2016.19.2.169. Epub 2016 Jun 24.
Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes
Kim SW11, Choi DH2, Huh SJ2, Park W2, Nam SJ3, Kim SW3, Lee JE3, Im YH4, Ahn JS4, Park YH4.
Clin Breast Cancer. 2016 Jun;16(3):e15-21. doi: 10.1016/j.clbc.2015.11.008. Epub 2015 Dec 11.
Limited Supraclavicular Radiation Field in Breast Cancer With >= 10 Positive Axillary Lymph Nodes
Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.
Medicine (Baltimore). 2016 Apr;95(16):e3299. doi: 10.1097/MD.0000000000003299.
Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database Matched-Pair Analysis of Patients With Female Breast Cancer
Choi MY11, Lee SK, Lee JE, Park HS, Lim ST, Jung Y, Ko BK, Nam SJ; Korean Breast Cancer Society.
Oncol Rep. 2016 Apr;35(4):2398-404. doi: 10.3892/or.2016.4557. Epub 2016 Jan 13.
MEK activity controls IL-8 expression in tamoxifen-resistant MCF-7 breast cancer cells
Kim S11, Jeon M1, Lee JE1, Nam SJ1.
Tumour Biol. 2016 Apr;37(4):4991-9. doi: 10.1007/s13277-015-4345-7. Epub 2015 Nov 4.
MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells
Kim S11, Lee J2, Jeon M2,3, Lee JE2,3, Nam SJ4.
BMC Cancer. 2016 Feb 22;16:138. doi: 10.1186/s12885-016-2195-3.
Prognostic value of ERBB4 expression in patients with triple negative breast cancer
Kim JY11, Jung HH2, Do IG3, Bae S4, Lee SK5, Kim SW6, Lee JE7, Nam SJ8, Ahn JS9, Park YH10,11, Im YH12,13.
Oncotarget. 2016 Jan 12;7(2):1544-58. doi: 10.18632/oncotarget.6441.
Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-beta 1 signaling pathway
Kim S11, Lee J1, Jeon M1,2, Lee JE1,2, Nam SJ1.
Oncotarget. 2015 Dec 22;6(41):43731-42. doi: 10.18632/oncotarget.6192.
Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer
Lee JY11, Park K2, Lim SH1, Kim HS1, Yoo KH1, Jung KS1, Song HN1, Hong M3, Do IG3, Ahn T2, Lee SK4, Bae SY4, Kim SW4, Lee JE4, Nam SJ4, Kim DH5, Jung HH6, Kim JY1, Ahn JS1, Im YH1, Park YH1.
Clin Breast Cancer. 2015 Dec;15(6):512-8. doi: 10.1016/j.clbc.2015.06.004. Epub 2015 Jun 18.
Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments
Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.
J Breast Cancer. 2015 Dec;18(4):386-93. doi: 10.4048/jbc.2015.18.4.386. Epub 2015 Dec 23.
Independent Prognostic Factors for Overall Survival after Salvage Operation for Ipsilateral Breast Tumor Recurrence Following Breast-Conserving Surgery
Lee JH11, Lee SK1, Park SM1, Ryu JM1, Paik HJ1, Yi HW1, Bae SY1, Lee JE1, Kim SW1, Nam SJ1.
Psychooncology. 2015 Dec;24(12):1723-30. doi: 10.1002/pon.3839. Epub 2015 May 26.
Patient-reported assessment of self-management strategies of health in cancer patients: development and validation of the Smart Management Strategy for Health Assessment Tool (SAT)
Yun YH11,2, Jung JY1, Sim JA1, Choi H1, Lee JM3, Noh DY2,4, Han W2,4, Park KJ4, Jeong SY4, Park JW4, Wu HG5, Chie EK5, Kim HJ5, Lee JH6, Zo ZI7, Kim S8, Lee JE8, Nam SJ8, Lee ES3, Oh JH3, Kim YW3, Kim YT2,9, Shim YM7.
Ann Surg Oncol. 2015 Oct;22(11):3481-8. doi: 10.1245/s10434-015-4399-1. Epub 2015 Feb 5.
The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean Women
Kim J11, Han W2, Jung SY3, Park YH4, Moon HG5, Ahn SK6, Lee JW7, Kim MK5, Kim JJ5, Lee ES5, You TK1, Kang HS3, Lee ES3, Ro J3, Lee JE4, Nam SJ4, Yim YH4, Park IA5, Noh DY5.
Cancer Res Treat. 2015 Oct;47(4):765-73. doi: 10.4143/crt.2014.168. Epub 2015 Jan 13.
Impact on Survival of Regular Postoperative Surveillance for Patients with Early Breast Cancer
Lee JY11, Lim SH1, Lee MY1, Kim H1, Kim M1, Kim S1, Jung HA1, Sohn I2, Gil WH3, Lee JE3, Kim SW3, Nam SJ3, Ahn JS1, Im YH1, Park YH1.
Technol Cancer Res Treat. 2015 Oct;14(5):525-9. doi: 10.7785/tcrt.2012.500415. Epub 2014 Nov 24.
Incidental Findings on Simulation CT Images for Adjuvant Radiotherapy in Breast Cancer Patients
Park JS11, Choi DH2, Huh SJ1, Park W1, Nam SJ3, Lee JE3, Kil WH3, Lee KS4.
Fam Cancer. 2015 Sep;14(3):365-71. doi: 10.1007/s10689-015-9789-9.
Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation
Kim H11, Cho DY, Choi DH, Jung GH, Shin I, Park W, Huh SJ, Kim SW, Park SK, Lee JW, Nam SJ, Lee JE, Gil WH, Kim SW.
J Breast Cancer. 2015 Sep;18(3):285-90. doi: 10.4048/jbc.2015.18.3.285. Epub 2015 Sep 24.
Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast
Park JS11, Choi DH1, Huh SJ1, Park W1, Kim YI2, Nam SJ3, Lee JE3, Kil WH3.
Oncol Rep. 2015 Sep;34(3):1613-9. doi: 10.3892/or.2015.4116. Epub 2015 Jul 8.
Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells
Kim S11, Lee J1, Oh SJ1, Nam SJ1, Lee JE1.
Cytokine. 2015 Sep;75(1):151-8. doi: 10.1016/j.cyto.2015.05.020. Epub 2015 Jun 15.
Elevated TGF-beta 1 and -beta 2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells
Kim S11, Lee J2, Jeon M3, Nam SJ2, Lee JE4.
Eur J Cancer Prev. 2015 Sep;24(5):422-9. doi: 10.1097/CEJ.0000000000000099.
Mammographic density and risk of breast cancer in Korean women
Kim BK11, Choi YH, Nguyen TL, Nam SJ, Lee JE, Hopper JL, Sung J, Song YM.
Oncotarget. 2015 Sep 15;6(27):24499-510.
Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay
Park K11, Choi MK2, Jung HH3, Do IG4, Lee KH5, Ahn T1, Kil WH6, Kim SW6, Lee JE6, Nam SJ6, Kim DH7, Ahn JS2, Im YH2,3, Park YH2,3.
PLoS One. 2015 Aug 4;10(8):e0124658. doi: 10.1371/journal.pone.0124658. eCollection 2015.
Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival
Lee SK11, Bae SY1, Lee JH1, Lee HC1, Yi H1, Kil WH1, Lee JE1, Kim SW1, Nam SJ1.
Breast Cancer Res Treat. 2015 Aug;152(3):675-82. doi: 10.1007/s10549-015-3502-4. Epub 2015 Jul 22.
Quantitative changes in skin composition parameters due to chemotherapy in breast cancer patients: a cohort study
Kang D11, Kim IR, Im YH, Park YH, Ahn JS, Lee JE, Nam SJ, Park H, Kim E, Lee HK, Lee DY, Cho J.
Aesthetic Plast Surg. 2015 Jun;39(3):369-76. doi: 10.1007/s00266-015-0493-9. Epub 2015 Apr 30.
Preoperative Magnetic Resonance Imaging-Based Breast Volumetry for Immediate Breast Reconstruction
Kim H11, Mun GH, Wiraatmadja ES, Lim SY, Pyon JK, Oh KS, Lee JE, Nam SJ, Bang SI.
Breast. 2015 Jun;24(3):213-7. doi: 10.1016/j.breast.2015.01.012. Epub 2015 Feb 24.
Prevalence and clinical outcomes of young breast cancer (YBC) patients according to intrinsic breast cancer subtypes: Single institutional experience in Korea
Park YH11, Lee SJ1, Jung HA1, Kim SM1, Kim MJ1, Kil WH2, Lee JE2, Nam SJ2, Ahn JS1, Im YH3.
Microsurgery. 2015 May;35(4):272-8. doi: 10.1002/micr.22328. Epub 2014 Sep 16.
Is Holm Zone III safe from fat necrosis in medial row perforator-based deep inferior epigastric perforator flaps
Lee KT11, Lee JE2, Nam SJ2, Han BK3, Mun GH1.
Oncology. 2015;88(6):337-44. doi: 10.1159/000368985. Epub 2015 Feb 25.
Immediate Postoperative Inflammation Is an Important Prognostic Factor in Breast Cancer
Lee SK11, Choi MY, Bae SY, Lee JH, Lee HC, Kil WH, Lee JE, Kim SW, Nam SJ.
Breast Cancer Res Treat. 2015 May;151(1):157-68. doi: 10.1007/s10549-015-3377-4. Epub 2015 Apr 12.
The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study
Kang E11, Seong MW, Park SK, Lee JW, Lee J, Kim LS, Lee JE, Kim SY, Jeong J, Han SA, Kim SW; Korean Hereditary Breast Cancer Study Group.
Exp Cell Res. 2015 Apr 10;333(1):116-26. doi: 10.1016/j.yexcr.2015.02.019. Epub 2015 Mar 3.
Induction of fibronectin by HER2 overexpression triggers adhesion and invasion of breast cancer cells
Jeon M11, Lee J2, Nam SJ2, Shin I3, Lee JE4, Kim S5.
ANZ J Surg. 2015 Apr;85(4):240-4.
Surgery of primary tumour has survival benefit in metastatic breast cancer with single-organ metastasis, especially bone
Rhu J1, Lee SK, Kil WH, Lee JE, Nam SJ.
Cancer Res Treat. 2015 Apr;47(2):208-14. doi: 10.4143/crt.2013.223. Epub 2014 Sep 11.
The Clinical Impact of 21-Gene Recurrence Score on Treatment Decisions for Patients with Hormone Receptor-Positive Early Breast Cancer in Korea
Lee MH11, Han W2, Lee JE3, Kim KS4, Park H5, Kim J2, Bae SY3, Shin HJ4, Lee JW5, Lee ES1.
Int J Cancer. 2015 Apr 15;136(8):1976-84. doi: 10.1002/ijc.29233. Epub 2014 Dec 24.
A seven-gene signature can predict distant recurrence in patients with triple- negative breast cancers who receive adjuvant chemotherapy following surgery
Park YH11, Jung HH, Do IG, Cho EY, Sohn I, Jung SH, Kil WH, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH.
Radiology. 2015 Apr;275(1):235-44. doi: 10.1148/radiol.14141129. Epub 2014 Dec 11.
Volume-based Metabolic Tumor Response to Neoadjuvant Chemotherapy Is Associated with an Increased Risk of Recurrence in Breast Cancer
Hyun SH11, Ahn HK, Park YH, Im YH, Kil WH, Lee JE, Nam SJ, Cho EY, Choi JY.
Surgery. 2015 Mar;157(3):518-25. doi: 10.1016/j.surg.2014.10.013. Epub 2014 Nov 6.
Lateral neck sentinel lymph node biopsy in papillary thyroid carcinoma, is it really necessary A randomized, controlled study
Lee SK11, Lee JH1, Bae SY1, Kim J1, Kim M1, Lee HC1, Jung YY2, Kil WH1, Kim SW1, Lee JE1, Nam SJ1, Choe JH1, Kim JH1, Kim JS3.
J Breast Cancer. 2015 Mar;18(1):50-6. doi: 10.4048/jbc.2015.18.1.50. Epub 2015 Mar 27.
Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission after Breast-Conserving Surgery in Women with Breast Cancer
Yu JI11, Choi DH1, Huh SJ1, Park W1, Nam SJ2, Kim SW2, Lee JE2, Kil WH2, Im YH3, Ahn JS3, Park YH3.
J Breast Cancer. 2015 Mar;18(1):22-8. doi: 10.4048/jbc.2015.18.1.22. Epub 2015 Mar 27.
Sentinel Lymph Node Biopsy Alone after Neoadjuvant Chemotherapy in Patients with Initial Cytology-Proven Axillary Node Metastasis
Kim JY11, Kim MK2, Lee JE3, Jung Y1, Bae SY3, Lee SK3, Kil WH3, Kim SW3, Kim KS4, Nam SJ3, Han S1.
BMC Cancer. 2015 Mar 18;15:138. doi: 10.1186/s12885-015-1121-4.
Poor prognosis of single hormone receptor-positive breast cancer: similar outcome as triple-negative breast cancer
Bae SY11, Kim S2, Lee JH3, Lee HC4, Lee SK5, Kil WH6, Kim SW7, Lee JE8, Nam SJ9.
Tumour Biol. 2015 Feb;36(2):1073-9. doi: 10.1007/s13277-014-2730-2. Epub 2014 Oct 19.
Prognostic relevance of biological subtype overrides that of TNM staging in breast cancer: discordance between stage and biology
Jung HA11, Park YH, Kim M, Kim S, Chang WJ, Choi MK, Hong JY, Kim SW, Kil WH, Lee JE, Nam SJ, Ahn JS, Im YH.
Oncol Rep. 2014 Dec;32(6):2666-72. doi: 10.3892/or.2014.3514. Epub 2014 Sep 24.
Zerumbone suppresses EGF-induced CD44 expression through the inhibition of STAT3 in breast cancer cells
Kim S11, Kil WH1, Lee J1, Oh SJ1, Han J1, Jeon M1, Jung T1, Lee SK1, Bae SY1, Lee HC1, Lee JH1, Yi HW1, Kim SW1, Nam SJ1, Lee JE1.
Hum Pathol. 2014 Dec;45(12):2480-7. doi: 10.1016/j.humpath.2014.08.015. Epub 2014 Sep 7.
Invasive Paget disease of the breast: 20 years of experience at a single institution
Lee HW11, Kim TE1, Cho SY1, Kim SW2, Kil WH2, Lee JE2, Nam SJ2, Cho EY3.
Phytother Res. 2014 Nov;28(11):1654-60. doi: 10.1002/ptr.5178. Epub 2014 May 30.
Zerumbone Suppresses IL-1 beta-induced Cell Migration and Invasion by Inhibiting IL-8 and MMP-3 Expression in Human Triple-negative Breast Cancer Cells
Han J11, Bae SY, Oh SJ, Lee J, Lee JH, Lee HC, Lee SK, Kil WH, Kim SW, Nam SJ, Kim S, Lee JE.
Oncol Rep. 2014 Nov;32(5):2230-6. doi: 10.3892/or.2014.3450. Epub 2014 Aug 29.
Induction of fibronectin in response to epidermal growth factor is suppressed by silibinin through the inhibition of STAT3 in triple negative breast cancer cells
Kim S11, Jeon M1, Lee J1, Han J1, Oh SJ1, Jung T1, Nam SJ1, Kil WH1, Lee JE1.
Asian Pac J Cancer Prev. 2014;15(20):8607-12.
Association between Socioeconomic Status and Altered Appearance Distress, Body Image, and Quality of Life Among Breast Cancer Patients
Chang O11, Choi EK, Kim IR, Nam SJ, Lee JE, Lee SK, Im YH, Park YH, Cho J.
Psychooncology. 2014 Oct;23(10):1103-10. doi: 10.1002/pon.3531. Epub 2014 Mar 24.
Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients
Choi EK11, Kim IR, Chang O, Kang D, Nam SJ, Lee JE, Lee SK, Im YH, Park YH, Yang JH, Cho J.
Ann Surg Treat Res. 2014 Oct;87(4):167-73. doi: 10.4174/astr.2014.87.4.167. Epub 2014 Sep 25.
Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells
Kil WH11, Kim SM1, Lee JE1, Park KS2, Nam SJ1.
Breast. 2014 Oct;23(5):586-90. doi: 10.1016/j.breast.2014.05.025. Epub 2014 Jun 23.
Excision alone for small size ductal carcinoma in situ of the breast
Kim H11, Noh JM2, Choi DH3, Lee J4, Nam SJ5, Lee JE5, Park W4, Huh SJ4.
Breast. 2014 Oct;23(5):670-5. doi: 10.1016/j.breast.2014.07.005. Epub 2014 Jul 31.
Ovarian function preservation with GnRH agonist in young breast cancer patients: Does it impede the effect of adjuvant chemotherapy
Kim J11, Kim M2, Lee JH2, Lee H2, Lee SK2, Bae SY2, Jun SY3, Kil WH2, Lee JE4, Kim SW2, Nam SJ2.
J Breast Cancer. 2014 Sep;17(3):279-86. doi: 10.4048/jbc.2014.17.3.279. Epub 2014 Sep 30.
Breast Cancer Screening Knowledge and Perceived Health Beliefs among Immigrant Women in Korea
Kim J11, Lee SK2, Lee J3, Choi MY3, Jung SP4, Kim MK2, Kim S2, Nam SJ2, Lee JE2, Kil WH2.
J Breast Cancer. 2014 Sep;17(3):244-9. doi: 10.4048/jbc.2014.17.3.244. Epub 2014 Sep 30.
Clinical Significance of the Axillary Arch in Sentinel Lymph Node Biopsy
Kil WH11, Lee JE1, Nam SJ1.
Cancer Chemother Pharmacol. 2014 Sep;74(3):521-9. doi: 10.1007/s00280-014-2542-5. Epub 2014 Jul 22.
Clinicopathological features of early failure of neoadjuvant chemotherapy in locally advanced breast cancer
Choi MK11, Park YH, Kil WH, Lee JE, Nam SJ, Ahn JS, Im YH.
Oncol Lett. 2014 Aug;8(2):507-512. Epub 2014 May 30.
Role of secreted type I collagen derived from stromal cells in two breast cancer cell lines
Kim SH11, Lee HY2, Jung SP2, Kim S3, Lee JE3, Nam SJ3, Bae JW2.
Tumour Biol. 2014 Jul;35(7):7079-84. doi: 10.1007/s13277-014-1952-7. Epub 2014 Apr 24.
Aberrant DNA methylation of integrin alpha 4 in human breast cancer
Do SI11, Ko E, Kang SY, Lee JE, Nam SJ, Cho EY, Kim DH.
Oncology. 2014;86(5-6):279-88. doi: 10.1159/000362281. Epub 2014 Jun 4.
Validation and Comparison of CS-IHC4 Scores with a Nomogram to Predict Recurrence in Hormone Receptor-Positive Breast Cancers
Park YH11, Im SA, Cho EY, Ahn JH, Woo SY, Kim S, Keam B, Lee JE, Han W, Nam SJ, Park IA, Noh DY, Yang JH, Ahn JS, Im YH.
Breast Cancer Res Treat. 2014 Jul;146(1):63-9. doi: 10.1007/s10549-014-3006-7. Epub 2014 Jun 4.
A multi-institutional study on the association between BRCA1/BRCA2 mutational status and triple-negative breast cancer in familial breast cancer patients
Seong MW11, Kim KH, Chung IY, Kang E, Lee JW, Park SK, Lee MH, Lee JE, Noh DY, Son BH, Park HL, Cho SI, Park SS; Korean Hereditary Breast Cancer Study Group, Kim SW.
J Radiat Res. 2014 May;55(3):553-8. doi: 10.1093/jrr/rrt141. Epub 2014 Jan 1.
Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection
Noh JM11, Choi DH, Park H, Huh SJ, Park W, Seol SW, Jeong BK, Nam SJ, Lee JE, Kil WH.
World J Surg. 2014 May;38(5):1065-9. doi: 10.1007/s00268-014-2468-4.
The Protective Effect of Parity in Hormone Receptor-Positive, Ki-67 Expressing Breast Cancer
Lee SK11, Kim SW, Han SA, Kil WH, Lee JE, Nam SJ.
Cancer Genet. 2014 Apr;207(4):160-3. doi: 10.1016/j.cancergen.2014.04.002. Epub 2014 Apr 12.
Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population
Noh JM11, Choi DH2, Baek H3, Kim MJ4, Park H1, Huh SJ1, Park W1, Nam SJ5, Lee JE5, Kil WH5, Haffty BG6.
Oncol Rep. 2014 Mar;31(3):1423-8. doi: 10.3892/or.2013.2936. Epub 2013 Dec 19.
Protein kinase C- a downregulates estrogen receptor- a by suppressing c- Jun phosphorylation in estrogen receptor- positive breast cancer cells
Kim S11, Lee J1, Lee SK1, Bae SY1, Kim J1, Kim M1, Kil WH1, Kim SW1, Lee JE1, Nam SJ1.
J Breast Cancer. 2014 Mar;17(1):83-7. doi: 10.4048/jbc.2014.17.1.83. Epub 2014 Mar 28.
Polyostotic Fibrous Dysplasia Mimicking Multiple Bone Metastases in a Patient with Ductal Carcinoma In Situ
Lee JH11, Kim SY2, Lee JE1, Cho EY3, Choi YL3, Choi JY4, Han SW2, Kim SW1, Kil WH1, Nam SJ1.
Ann Oncol. 2014 Feb;25(2):346-51. doi: 10.1093/annonc/mdt476. Epub 2013 Dec 29.
Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients
Cho J11, Choi EK, Kim IR, Im YH, Park YH, Lee S, Lee JE, Yang JH, Nam SJ.
Cancer Res Treat. 2014 Jan;46(1):104-7. doi: 10.4143/crt.2014.46.1.104. Epub 2014 Jan 15.
Primary Follicular Lymphoma in a Male Breast: A Case Report
Jung SP11, Han KM2, Kim SJ3, Nam SJ4, Bae JW1, Lee JE4.
Int J Radiat Biol. 2014 Jan;90(1):90-4. doi: 10.3109/09553002.2013.835504. Epub 2013 Sep 19.
Acute skin toxicity in Korean breast cancer patients carrying BRCA mutations
Park H11, Choi DH, Noh JM, Huh SJ, Park W, Nam SJ, Lee JE.
Cell Physiol Biochem. 2013;32(5):1541-50. doi: 10.1159/000356591. Epub 2013 Nov 29.
Berberine Suppresses TPA-Induced Fibronectin Expression through the Inhibition of VEGF Secretion in Breast Cancer Cells
Kim S11, Oh SJ, Lee J, Han J, Jeon M, Jung T, Lee SK, Bae SY, Kim J, Gil WH, Kim SW, Lee JE, Nam SJ.
J Breast Cancer. 2013 Dec;16(4):417-25. doi: 10.4048/jbc.2013.16.4.417. Epub 2013 Dec 31.
Comparison of the Characteristics of Medullary Breast Carcinoma and Invasive Ductal Carcinoma
Park I11, Kim J1, Kim M1, Bae SY1, Lee SK1, Kil WH1, Lee JE1, Nam SJ1.
Ann Surg Oncol. 2013 Oct;20(10):3341-7. doi: 10.1245/s10434-013-3175-3. Epub 2013 Aug 22.
Round Block Technique Without Cerclage in Breast-Conserving Surgery
Kim MK11, Kim J, Jung SP, Bae SY, Choi MY, Lee SK, Kim S, Kil WH, Kim SW, Kim JH, Kim JS, Nam SJ, Lee JE.
J Breast Cancer. 2013 Sep;16(3):345-8. doi: 10.4048/jbc.2013.16.3.345. Epub 2013 Sep 30.
Breast Metastasis from Rhabdomyosarcoma of the Anus in an Adolescent Female
Jung SP11, Lee Y, Han KM, Lee SK, Kim S, Bae SY, Kim J, Kim M, Kim S, Kil WH, Koo HH, Nam SJ, Bae JW, Lee JE.
J Korean Surg Soc. 2013 Jul;85(1):1-6. doi: 10.4174/jkss.2013.85.1.1. Epub 2013 Jun 26.
Experience of treatment of patients with granulomatous lobular mastitis
Hur SM11, Cho DH, Lee SK, Choi MY, Bae SY, Koo MY, Kim S, Choe JH, Kim JH, Kim JS, Nam SJ, Yang JH, Lee JE.
Breast Cancer Res Treat. 2013 Jun;139(3):741-50. doi: 10.1007/s10549-013-2570-6. Epub 2013 May 31.
HER3 status by immunohistochemistry is correlated with poor prognosis in hormone receptor-negative breast cancer patients
Bae SY11, La Choi Y, Kim S, Kim M, Kim J, Jung SP, Choi MY, Lee SK, Kil WH, Lee JE, Nam SJ.
J Korean Surg Soc. 2013 May;84(5):273-80. doi: 10.4174/jkss.2013.84.5.273. Epub 2013 Apr 24.
Neoadjuvant human epidermal growth factor receptor-2 targeted therapy in patients with locally advanced breast cancer
Cho DH11, Lee SK, Kim S, Choi MY, Jung SP, Lee J, Kim J, Koo MY, Bae SY, Kim JH, Kim JS, Ho KW, Lee JE, Nam SJ, Yang JH.
J Korean Surg Soc. 2013 May;84(5):267-72. doi: 10.4174/jkss.2013.84.5.267. Epub 2013 Apr 24.
Primary breast lymphoma: a single institution's experience
Jung SP11, Kim M, Han KM, Kim JH, Kim JS, Nam SJ, Bae JW, Lee JE.
J Breast Cancer. 2013 Mar;16(1):97-103. doi: 10.4048/jbc.2013.16.1.97. Epub 2013 Mar 31.
Validation of a Web-Based Tool to Predict the Ipsilateral Breast Tumor Recurrence (IBTR! 2.0) after Breast-Conserving Therapy for Korean Patients
Jung SP11, Hur SM, Lee SK, Kim S, Choi MY, Bae SY, Kim J, Kim MK, Kil WH, Choe JH, Kim JH, Kim JS, Nam SJ, Bae JW, Lee JE.
Fam Cancer. 2013 Mar;12(1):75-81. doi: 10.1007/s10689-012-9578-7.
The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study
Han SA11, Kim SW, Kang E, Park SK, Ahn SH, Lee MH, Nam SJ, Han W, Bae YT, Kim HA, Cho YU, Chang MC, Paik NS, Hwang KT, Kim SJ, Noh DY, Choi DH, Noh WC, Kim LS, Kim KS, Suh YJ, Lee JE, Jung Y, Moon BI, Yang JH, Son BH, Yom CK, Kim SY, Lee H, Jung SH; KOHBRA Research Group and the Korean Breast Cancer Society.
J Breast Cancer. 2012 Sep;15(3):296-305. doi: 10.4048/jbc.2012.15.3.296. Epub 2012 Sep 28.
Adjuvant Chemotherapy and Survival of Elderly Korean Patients with Breast Carcinoma
Jung SP11, Lee JE, Lee SK, Kim S, Choi MY, Bae SY, Kim J, Kil WH, Choe JH, Kim JH, Kim JS, Nam SJ.
J Breast Cancer. 2012 Sep;15(3):359-63. doi: 10.4048/jbc.2012.15.3.359. Epub 2012 Sep 28.
Occult Breast Cancers Manifesting as Axillary Lymph Node Metastasis in Men: A Two-Case Report
Hur SM11, Cho DH, Lee SK, Choi MY, Bae SY, Koo MY, Kim S, Nam SJ, Lee JE, Yang JH.
J Breast Cancer. 2012 Sep;15(3):313-9. doi: 10.4048/jbc.2012.15.3.313. Epub 2012 Sep 28.
Invasive Pleomorphic Lobular Carcinoma of the Breast: Clinicopathologic Characteristics and Prognosis Compared with Invasive Ductal Carcinoma
Jung SP11, Lee SK, Kim S, Choi MY, Bae SY, Kim J, Kim M, Kil WH, Cho EY, Choe JH, Kim JH, Kim JS, Nam SJ, Lee JE.
Breast Cancer Res Treat. 2012 Aug;134(3):1189-97. doi: 10.1007/s10549-012-2022-8. Epub 2012 Mar 22.
Accuracy of BRCA1/2 mutation prediction models in Korean breast cancer patients
Kang E11, Park SK, Yang JJ, Park B, Lee MH, Lee JW, Suh YJ, Lee JE, Kim HA, Oh SJ, Kim SW; Korean Breast Cancer Society.
Exp Mol Med. 2012 Aug 31;44(8):473-82. doi: 10.3858/emm.2012.44.8.054.
A functional comparison between the HER2(high)/HER3 and the HER2l(ow/)HER3 dimers on heregulin-beta 1-induced MMP-1 and MMP-9 expression in breast cancer cells
Kim S11, Han J, Shin I, Kil WH, Lee JE, Nam SJ.
Ann Surg Oncol. 2012 Aug;19(8):2612-7. doi: 10.1245/s10434-012-2307-5. Epub 2012 Apr 4.
Clinicopathologic Risk Factors for the Local Recurrence of Phyllodes Tumors of the Breast
Jang JH11, Choi MY, Lee SK, Kim S, Kim J, Lee J, Jung SP, Choe JH, Kim JH, Kim JS, Cho EY, Lee JE, Nam SJ, Yang JH.
J Surg Res. 2012 Jul;176(1):e21-9. doi: 10.1016/j.jss.2011.11.1041. Epub 2011 Dec 30.
Berberine Suppresses the TPA-Induced MMP-1 and MMP-9 Expressions Through the Inhibition of PKC-alpha in Breast Cancer Cells
Kim S11, Han J, Lee SK, Choi MY, Kim J, Lee J, Jung SP, Kim JS, Kim JH, Choe JH, Lee JE, Nam SJ.
J Breast Cancer. 2012 Jun;15(2):230-8. doi: 10.4048/jbc.2012.15.2.230. Epub 2012 Jun 28.
Development of Novel Breast Cancer Recurrence Prediction Model Using Support Vector Machine
Kim W11, Kim KS, Lee JE, Noh DY, Kim SW, Jung YS, Park MY, Park RW.
Breast Cancer Res Treat. 2012 Jun;133(3):1143-52. doi: 10.1007/s10549-012-2001-0. Epub 2012 Mar 2.
Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study
Son BH11, Ahn SH, Kim SW, Kang E, Park SK, Lee MH, Noh WC, Kim LS, Jung Y, Kim KS, Noh DY, Moon BI, Suh YJ, Lee JE, Choi DH, Kim SY, Jung SH, Yom CK, Lee H, Yang JH; KOHBRA Research Group and Korean Breast Cancer Society.
Asian Pac J Cancer Prev. 2012;13(4):1383-8.
Perception, Attitudes, Preparedness and Experience of Chemotherapy-Induced Alopecia among Breast Cancer Patients: a Qualitative Study
Kim IR11, Cho J, Choi EK, Kwon IG, Sung YH, Lee JE, Nam SJ, Yang JH.
J Hum Genet. 2012 Mar;57(3):212-5. doi: 10.1038/jhg.2011.139. Epub 2012 Jan 5.
Spectra of BRCA1 and BRCA2 mutations in Korean patients with breast cancer: the importance of whole-gene sequencing
Jang JH11, Lee JE, Kwon MJ, Ki CS, Kim JW, Nam SJ, Yang JH.
PLoS One. 2012;7(3):e33238. doi: 10.1371/journal.pone.0033238. Epub 2012 Mar 29.
Efficacy of an Educational Material on Second Primary Cancer Screening Practice for Cancer Survivors: A Randomized Controlled Trial
Shin DW11, Cho J, Kim YW, Oh JH, Kim SW, Chung KW, Lee WY, Lee JE, Guallar E, Lee WC.
Oncol Rep. 2012 Feb;27(2):517-22. doi: 10.3892/or.2011.1511. Epub 2011 Oct 20.
TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells
Han J11, Kim S, Yang JH, Nam SJ, Lee JE.
Breast Cancer Res Treat. 2012 Jan;131(2):527-40. doi: 10.1007/s10549-011-1836-0. Epub 2011 Oct 30.
Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes
Kim J11, Lee S, Bae S, Choi MY, Lee J, Jung SP, Kim S, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.
Oncol Rep. 2012 Jan;27(1):210-5. doi: 10.3892/or.2011.1480. Epub 2011 Sep 29.
Effect of berberine on p53 expression by TPA in breast cancer cells
Kim S11, Han J, Kim NY, Lee SK, Cho DH, Choi MY, Kim JS, Kim JH, Choe JH, Nam SJ, Lee JE.
Cancer Lett. 2012 Jan 28;314(2):147-54. doi: 10.1016/j.canlet.2011.09.024. Epub 2011 Sep 29.
Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells
Kim S11, Han J, Lee SK, Koo M, Cho DH, Bae SY, Choi MY, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.
J Breast Cancer. 2011 Dec;14(4):308-13. doi: 10.4048/jbc.2011.14.4.308. Epub 2011 Dec 27.
Mucinous Carcinoma of the Breast in Comparison with Invasive Ductal Carcinoma: Clinicopathologic Characteristics and Prognosis
Bae SY11, Choi MY, Cho DH, Lee JE, Nam SJ, Yang JH.
J Breast Cancer. 2011 Dec;14(4):322-7. doi: 10.4048/jbc.2011.14.4.322. Epub 2011 Dec 27.
Does Immediate Breast Reconstruction after Mastectomy affect the Initiation of Adjuvant Chemotherapy
Lee J11, Lee SK, Kim S, Koo MY, Choi MY, Bae SY, Cho DH, Kim J, Jung SP, Choe JH, Kim JH, Kim JS, Lee JE, Yang JH, Nam SJ.
Surg Today. 2011 Dec;41(12):1665-9. doi: 10.1007/s00595-011-4503-5. Epub 2011 Oct 4.
Ileal Metastasis of Breast Cancer in a Patient with a BRCA2 Gene Mutation: Report of a Case
Cho DH11, Jeon YS, Choi MY, Lee SK, Kim SM, Hur SM, Koo MY, Bae SY, Choe JH, Kim JH, Kim JS, Nam SJ, Yang JH, Lee JE.
Anticancer Res. 2011 Nov;31(11):3767-73.
Silibinin Suppresses EGFR Ligand-induced CD44 Expression through Inhibition of EGFR Activity in Breast Cancer Cells
Kim S11, Han J, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.
World J Surg. 2011 Nov;35(11):2417-21. doi: 10.1007/s00268-011-1225-1.
Large Clinical Experience of Primary Angiosarcoma of the Breast in a Single Korean Medical Institute
Bae SY11, Choi MY, Cho DH, Lee JE, Nam SJ, Yang JH.
J Breast Cancer. 2011 Sep;14(3):251-2. doi: 10.4048/jbc.2011.14.3.251. Epub 2011 Sep 29.
Invited Commentary on: Can CD44+/CD24-Tumor Stem Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy
Lee JE11, Nam SJ.
Yonsei Med J. 2011 Sep;52(5):803-8. doi: 10.3349/ymj.2011.52.5.803.
Results from Over One Year of Follow-Up for Absorbable Mesh Insertion in Partial Mastectomy
Koo MY11, Lee SK, Hur SM, Bae SY, Choi MY, Cho DH, Kim S, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.
Cancer. 2011 Aug 15;117(16):3850-9. doi: 10.1002/cncr.25951. Epub 2011 Feb 11.
Knowledge, Attitudes, Risk Perception, and Cancer Screening Behaviors Among Cancer Survivors
Shin DW11, Kim YW, Oh JH, Kim SW, Chung KW, Lee WY, Lee JE, Lee WC, Guallar E, Cho J.
J Breast Cancer. 2011 Jun;14(2):165-6. doi: 10.4048/jbc.2011.14.2.165. Epub 2011 Jun 18.
Commentary on: Incidental Breast Cancers Identified in a One-Stop Symptomatic Breast Clinic
Lee JE11, Yang JH, Nam SJ.
Breast Cancer Res Treat. 2011 Apr;126(2):471-8. doi: 10.1007/s10549-011-1359-8. Epub 2011 Feb 2.
The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients
Bae SY11, Lee SK, Koo MY, Hur SM, Choi MY, Cho DH, Kim S, Choe JH, Lee JE, Kim JH, Kim JS, Nam SJ, Yang JH.
World J Surg. 2011 Mar;35(3):573-9. doi: 10.1007/s00268-010-0942-1.
Cases and Literature Review of Breast Sparganosis
Koo M11, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.
J Breast Cancer. 2011 Mar;14(1):33-8. doi: 10.4048/jbc.2011.14.1.33. Epub 2011 Mar 31.
The 70-Gene Prognostic Signature for Korean Breast Cancer Patients
Na KY11, Kim KS, Lee JE, Kim HJ, Yang JH, Ahn SH, Moon BI, Kim RM, Ko SM, Jung YS.
Survey of Psychosocial Problems Facing Breast Cancer Survivors after Undergoing a Mastectomy and Their Awareness of Breast Reconstruction
The Change of Practice Patterns of the Hereditary Breast Cancer Management in Korea after the Korean Hereditary Breast Cancer Study
Phytomedicine. 2010 Dec 1;17(14):1127-32. doi: 10.1016/j.phymed.2010.03.013.
12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth arrest is increased by silibinin by the down-regulation of cyclin B1 and cdc2 and the up-regulation of p21 expression in MDA-MB231 human breast cancer cells
Kim S11, Lee HS, Lee SK, Kim SH, Hur SM, Kim JS, Kim JH, Choe JH, Shin I, Yang JH, Lee JE, Nam SJ.
Pharmacology. 2010;86(5-6):313-9. doi: 10.1159/000321327. Epub 2010 Nov 11.
Pifithrin-alpha an Inhibitor of p53 Transactivation, Up-Regulates COX-2 Expression through an MAPK-Dependent Pathway
Kim S11, Han J, Lee SK, Hur SM, Koo M, Cho DH, Bae SY, Choi MY, Shin I, Yang JH, Nam SJ, Lee JE.
Single-Port Access Laparoscopic Prophylactic Bilateral Salpingo-Oophorectomy in BRCA-Positive Breast Cancer Patient: A Case Report
Secondary Partial Mastectomy with Contralateral Sentinel Lymph Node Biopsy for Ipsilateral Breast Cancer Recurrence after Conservative Surgery: Report of 2 Cases
Incidental Detection of Ductal Carcinoma In Situ of the Breast from Bilateral Prophylactic Mastectomy of Asymptomatic BRCA2 Mutation Carrier: A Case Report
Biopsychosocial Predictors of the Quality of Life in Breast Cancer Patients
The Preoperative Role of Breast-specific Gamma Imaging for the Breast Cancer Patients: In Comparison with Conventional Imaging Modality
Characteristics of Invasive Micropapillary Carcinoma of the Breast: In Comparison with Invasive Ductal Carcinoma
Intracystic Papillary Carcinoma in the Male Breast
J Surg Oncol. 2010 Feb 1;101(2):137-40. doi: 10.1002/jso.21453.
Characteristics of Metastasis in the Breast From Extramammary Malignancies
Lee SK11, Kim WW, Kim SH, Hur SM, Kim S, Choi JH, Cho EY, Han SY, Hahn BK, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.
Implications of Isolated Tumor Cells in Sentinel Lymph Nodes of Breast Cancer Patients
Arm Sentinel Lymph Node Detection for Preserving the Arm Lymphatic System
Experience with Intracystic Papillary Carcinoma of the Breast at a Single Institute in Korea
Molecules. 2009 Oct 26;14(11):4300-11. doi: 10.3390/molecules14114300.
Silibinin Suppresses TNF-alpha-Induced MMP-9 Expression in Gastric Cancer Cells through Inhibition of the MAPK Pathway
Kim S11, Choi MG, Lee HS, Lee SK, Kim SH, Kim WW, Hur SM, Kim JH, Choe JH, Nam SJ, Yang JH, Kim S, Lee JE, Kim JS.
J Ethnopharmacol. 2009 Nov 12;126(2):252-7. doi: 10.1016/j.jep.2009.08.032. Epub 2009 Aug 26.
Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells
Kim S11, Kim SH, Hur SM, Lee SK, Kim WW, Kim JS, Kim JH, Choe JH, Nam SJ, Lee JE, Yang JH.
Cell Signal. 2009 Jun;21(6):892-8.
EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line
Kim S11, Choi JH, Lim HI, Lee SK, Kim WW, Cho S, Kim JS, Kim JH, Choe JH, Nam SJ, Lee JE, Yang JH.
The Breast and Ovarian Cancer Risks in Korea Due to Inherited Mutations in BRCA1 and BRCA2: A Preliminary Report
Phytomedicine. 2009 Jun;16(6-7):573-80. doi: 10.1016/j.phymed.2008.11.006. Epub 2009 Jan 31.
Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells
Kim S11, Choi JH, Lim HI, Lee SK, Kim WW, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.
Breast J. 2013 Jul-Aug;19(4):388-93. doi: 10.1111/tbj.12122. Epub 2013 May 31.
The Impact of the Ratio of Positive Nodes to Removed Nodes on Recurrence and Overall Survival in Node Positive Breast Cancer Patients
Martin FT11, O'Fearraigh C, Hanley C, Curran C, Sweeney KJ, Kerin MJ.
Molecules. 2008 Dec 3;13(12):2975-85. doi: 10.3390/molecules13122975.
Berberine Suppresses TNF-alpha-induced MMP-9 and Cell Invasion through Inhibition of AP-1 Activity in MDA-MB-231 Human Breast Cancer Cells
Kim S11, Choi JH, Kim JB, Nam SJ, Yang JH, Kim JH, Lee JE.
J Breast Cancer. 2011 Jun;14(2):165-6. doi: 10.4048/jbc.2011.14.2.165. Epub 2011 Jun 18.
Breast cancer stem cells: Changing therapeutic paradigm
Lee JE11, Yang JH, Nam SJ.
Yonsei Med J. 2007 Jun 30;48(3):465-73.
Analysis of prognostic factors and treatment modality changes in breast cancer: A single institution study in Korea
Lee WS11, Lee JE, Kim JH, Nam SJ, Yang JH.
